Develop bowel preparation strategies based on the patient's bowel habits

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050437

Enrollment

Unknown

Registered

2021-08-27

Start date

2021-08-15

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group A (Stool trait type 1 or 2):3L PEG

Group B:3L PEG +Linaclotide (290ug)

Group C (Stool trait type 1 or 2):3L PEG

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent; 2. Patients aged 18-65 years who undergo colonoscopy, regardless of gender; 3. Take the medicine for cleaning the intestines correctly according to the project requirements.

Exclusion criteria

Exclusion criteria: 1. History of colorectal surgery; 2. Severe heart failure (New York Heart Class II-IV); 3. Chronic renal failure (stage 2-5) or mental disorder; 4. History of taking linaclotide within 7 days or known history of linaclotide allergy; 5. Patients who are participating in other clinical trials.

Design outcomes

Secondary

Measure	Time frame
Polyp/adenoma detection rate;Adverse reactions;	—

Primary

Measure	Time frame
Degree of bowel cleansing;	—

Countries

China

Contacts

Public ContactLiao Jiazhi

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

liaojiazhi@tjh.tjmu.edu.cn+86 13986126936

Outcome results